Search research articles
Contact Us
Filters
Showing results (541-550 of 580) with videos related to
Page
of 58
Sort By:
Journal of Medicinal Chemistry
|
April 10, 2014
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia
Martha J Kelly, Sherrie Pietranico-Cole, J Douglas Larigan, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2010
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads
Yifang Huang, Eric D Strobel, Chih Y Ho, et al.
Mutation Research
|
December 20, 2011
Single-walled carbon nanotube-induced mitotic disruption
L M Sargent, A F Hubbs, S-H Young, et al.
Brain : a Journal of Neurology
|
January 9, 2023
Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxia
Zhongbo Chen, Arianna Tucci, Valentina Cipriani, et al.
The Lancet. Neurology
|
December 20, 2020
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
Edwin Jabbari, Shunsuke Koga, Rebecca R Valentino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2016
Clinicopathologic Features of Advanced Squamous NSCLC
Mark A Socinski, Coleman Obasaju, David Gandara, et al.
Brain : a Journal of Neurology
|
October 7, 2021
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
Naciye Magusali, Andrew C Graham, Thomas M Piers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer
Jyoti D Patel, Mark A Socinski, Edward B Garon, et al.
Nature Communications
|
April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivities
Tripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
Brain : a Journal of Neurology
|
November 9, 2022
Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia
Raquel Real, Alejandro Martinez-Carrasco, Regina H Reynolds, et al.
Page
of 58
Search research articles
Search
Showing results (541-550 of 580) with videos related to
Sort By:
Page
of 58
Journal of Medicinal Chemistry
|
April 10, 2014
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia
Martha J Kelly, Sherrie Pietranico-Cole, J Douglas Larigan, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2010
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads
Yifang Huang, Eric D Strobel, Chih Y Ho, et al.
Mutation Research
|
December 20, 2011
Single-walled carbon nanotube-induced mitotic disruption
L M Sargent, A F Hubbs, S-H Young, et al.
Brain : a Journal of Neurology
|
January 9, 2023
Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxia
Zhongbo Chen, Arianna Tucci, Valentina Cipriani, et al.
The Lancet. Neurology
|
December 20, 2020
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
Edwin Jabbari, Shunsuke Koga, Rebecca R Valentino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 15, 2016
Clinicopathologic Features of Advanced Squamous NSCLC
Mark A Socinski, Coleman Obasaju, David Gandara, et al.
Brain : a Journal of Neurology
|
October 7, 2021
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
Naciye Magusali, Andrew C Graham, Thomas M Piers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer
Jyoti D Patel, Mark A Socinski, Edward B Garon, et al.
Nature Communications
|
April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivities
Tripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
Brain : a Journal of Neurology
|
November 9, 2022
Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia
Raquel Real, Alejandro Martinez-Carrasco, Regina H Reynolds, et al.
Page
of 58